ReviewTherapeutic advances in ophthalmology
Advances in IOL calculations in patients with keratoconus.
Review in Therapeutic advances in ophthalmology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Management of astigmatism in keratoconus with therapeutic refractive surgery.Frontiers in medicine · 2026Review
- Challenges in Biometry and Intraocular Lens Power Calculations in Keratoconus: A Review.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Keratoconus is a progressive ectatic corneal disease characterized by corneal thinning, steepening, and irregular astigmatism, presenting unique challenges for intraocular lens (IOL) calculations in cataract surgery. The use of traditional formulas for IOL calculations in eyes with keratoconus frequently leads to significant refractive prediction errors, often resulting in a hyperopic shift, which can lead to suboptimal outcomes and reduced patient satisfaction. This review examines the impact of keratoconus on IOL calculations and highlights recent advancements in formulas specifically designed for eyes with keratoconus, particularly the Barrett True-K and the Kane Keratoconus formulas. We assess the effectiveness of these formulas based on the current literature and provide clinical recommendations aimed at improving surgical outcomes in this complex patient group.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.